Search Results
Jun 29, 2026, 12:48 ET Hood College Launches Accelerated One-Year Master of Science in Environmental Biology Track
New 30 credit track offers advanced credentials, practical research opportunitiesFREDERICK, Md., June 29, 2026 /PRNewswire/ -- Beginning in Fall 2026, Hood College's Graduate School will offer a new accelerated,
More news about: Hood College
Jun 29, 2026, 12:39 ET BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
oncology practices — by using Response, a physician has information two treatment cycles earlier than they would when using imaging alone," said Ali Zaidi, MD, Professor of Surgery and Medicine at Drexel University College of Medicine; Medical Director of Aerodigestive Research at Allegheny Cancer Institute,
More news about: BillionToOne
Jun 29, 2026, 11:34 ET Galen Hope Study Finds Significant Improvement in Eating Disorder Symptoms Across Age Groups Through Family-Centered Treatment Model
step of the process."The study's authors include Renée D. Rienecke, PhD, FAED; Maria Bazo Perez, PhD; Amy Boyers, PhD; and Wendy Oliver-Pyatt, MD, of Galen Hope. Dr. Rienecke is also affiliated with the Department of Psychiatry and Behavioral Sciences at Northwestern University.The full study,
More news about: Galen Hope Holdings, LLC
Jun 29, 2026, 11:00 ET Biopharma Communications Veterans Launch Valence Communications
high-stakes communications programs. Led by Founder and CEO Matt Middleman, MD, alongside Co-Founders and EVPs Dan Perlmutter, Brittany Leigh, PhD, and Jason Braco, PhD, Valence brings together senior agency leadership and MD- and PhD-level scientific expertise to deliver sharper counsel, stronger work,
More news about: Valence Communications
Jun 29, 2026, 11:00 ET USPS Announces Additional Stamps and Release Locations for 2026
Linthicum HeightsMD21090
More news about: U.S. Postal Service
Jun 29, 2026, 10:23 ET Dupilumab Improves Outcomes for EoG in Phase 2 Clinical Trial
biological processes that drive the disease," says Nirmala Gonsalves, MD, an esophageal expert and Professor of Medicine at Northwestern University School of Medicine, Chicago, who served as co-lead author of the study with Evan Dellon, MD, MPH, a gastroenterology expert and Professor at University of North
More news about: Cincinnati Children's Hospital Medical Center
Jun 29, 2026, 10:08 ET The Best Spine Surgery Is the One You Never Need: Harvard-Trained Spine Surgeon Releases Landmark Book on Preventing Chronic Low Back Pain
June 29, 2026 /PRNewswire/ -- Orthopedic spine surgeon, inventor, educator, and author Babajide Ogunseinde, MD, FAAOS, ABPS, announces the release of his fourth book, The Coach Before the Scalpel: A Surgeon and a Coach's Guide to Preventing Obesity, Chronic
More news about: PML Mastery
Jun 29, 2026, 10:00 ET Lupus Canada Funds Innovative Pediatric Lupus Research Through Partnership with the Lupus Foundation of America
2026 Lupus Canada Catalyst Grant to Andrea Knight, MD, MSCE, Associate Professor, Division of Rheumatology and Associate Scientist, Neurosciences and Mental Health, The Hospital for Sick Children (SickKids)
More news about: Lupus Foundation of America, Inc.
Jun 29, 2026, 09:30 ET NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
central questions in ALS drug development is whether a therapy is truly affecting the underlying biology of the disease," said Prof. Merit Cudkowicz, MD, MSc, Director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, and Professor of Neurology at Harvard Medical School.
More news about: NeuroSense
Jun 29, 2026, 09:01 ET New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults
expert consensus, thanks to the efforts of the ADA's Professional Practice Committee (PPC) and PPC section leads Kimberly A. Gudzune, MD, MPH, and Leigh Perreault, MD, FACE, FACP. About the Obesity Association Obesity is a chronic disease affecting millions of people in the U.S.
More news about: American Diabetes Association
Jun 29, 2026, 09:00 ET eNavvi Achieves Surescripts® E-Prescribing Certification
"Achieving Surescripts E-Prescribing certification is a milestone for eNavvi and for the clinicians who rely on us every day," said Teja Pathakota, MD, MBA, Chief Compliance Officer at eNavvi. "Connecting to Surescripts E-Prescribing technology means our providers can prescribe with greater confidence
More news about: eNavvi
Jun 29, 2026, 09:00 ET At a Turning Point for RAS-directed Therapies, Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative
Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, MIT's Koch Institute for Integrative Cancer Research, The University of Texas MD Anderson Cancer Center, and NYU Langone Health Perlmutter Cancer Center, to tackle these challenges through an integrated program of translational science
More news about: Break Through Cancer
Jun 29, 2026, 09:00 ET TrilliumBiO and The LAM Foundation Partner to Advance LAM Awareness and Education
include support for earlier diagnosis through LAMair™, TrilliumBiO's newly developed VEGF‑D testROCKVILLE, Md. and CINCINNATI, June 29, 2026 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision
More news about: TrilliumBiO
Jun 29, 2026, 08:49 ET DISC Surgery Center at Palm Beach Opens with Elite Team of Spine, Total Joint and Orthopedic Specialists
Milad Alam, MDJahangir Asghar, MD
More news about: DISC Surgery Center
Jun 29, 2026, 08:33 ET Consano Bio Highlights Scientific Advisory Board for C-1101, a Potential First-in-Class, Non-Opioid Therapy in Development for Chronic Sciatica
global regulatory strategies for drugs and biologics. Mihir Kamdar, MD, a Pain Medicine and Palliative Care physician at Massachusetts General Hospital and faculty member at Harvard Medical School. Ralph Vassallo, MD, Executive Vice President and Chief Medical and Scientific Officer at Vitalant,
More news about: Consano Bio
Jun 29, 2026, 08:30 ET MDJM Ltd. Appoints Goya Award-Winning Animation Producer Chelo Loureiro as Chief Knowledge Officer
focused on creating long-term value through cultural industries, international collaboration, industrial integration, and strategic resource allocation. MD Local Global Ltd. is the cultural business platform of MDJM Ltd., focused on original animation IP development, the digital animation museum, and the
More news about: MDJM Ltd.
Jun 29, 2026, 08:30 ET MDJM Ltd. Appoints Sinologist Professor Duncan Murray Campbell as Director
focused on creating long-term value through cultural industries, international collaboration, industrial integration and strategic resource allocation. MD Local Global Ltd. is the cultural business platform of MDJM Ltd., focused on original animation IP development, the digital animation museum, and the
More news about: MDJM Ltd.
Jun 29, 2026, 08:00 ET Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States
completed the first procedure using its OPUSWAVE® Dual Sensor Imaging System. The procedure, performed on June 15 by Annapoorna S. Kini, MD, MRCP, FACC, at Mount Sinai Fuster Heart Hospital in New York, represents a significant milestone in advancing intravascular imaging in the United States.
More news about: Terumo
Jun 29, 2026, 08:00 ET Arthritis & Osteoporosis Consultants of the Carolinas Treats First Patient in North Carolina with the SetPoint System®, a Device-based Treatment for Rheumatoid Arthritis
Osteoporosis Consultants of the Carolinas (AOCC), the largest independent rheumatology practice in the Southeast. The patient was referred by Ashley Toci, MD, FACR, CCD, rheumatologist at AOCC. This marks another step in SetPoint Medical's efforts to bring the treatment to patients nationwide, expanding access
More news about: SetPoint Medical
Jun 29, 2026, 08:00 ET One Brooklyn Health Selects hellocare.ai to Advance AI-Powered Virtual Care Across Its Hospitals
Health, we are committed to leveraging innovation to deliver safer, more equitable, and higher-quality care to our communities," said Sandra Scott, MD, Chief Executive Officer of One Brooklyn Health. "By partnering with hellocare.ai, we are equipping our clinicians with advanced AI tools that allow them
More news about: hellocare
Jun 29, 2026, 07:30 ET Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease
therapy has been approved for Graves' disease. BHV-1300 is designed to change the treatment landscape for this autoimmune disease.Beth Emerson, MD, MBA, Executive Medical Director at Biohaven and Lead for the Graves' disease clinical trial, commented, "The enrollment of the first patient in this
More news about: Biohaven Ltd.
Jun 29, 2026, 07:05 ET REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
AMD programs to be presented at American Society of Retina Specialists (ASRS) 2026ROCKVILLE, Md., June 29, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the first patient has been dosed
More news about: REGENXBIO Inc.
Jun 29, 2026, 07:00 ET Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
entry expected in 1Q 2027Leadership team includes industry veterans, CEO Marc Schegerin, MD, MBA and CMO Fabio Nunes, MD, MMSc, with Praveen Tipirneni, MD, MBA joining the boardNEW YORK and WESTFIELD, N.J., June
More news about: Talawar Therapeutics
Jun 29, 2026, 07:00 ET Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale
loop on value-based care – ensuring that identified health gaps are proactively addressed, documented and reflected in performance," said Jonah Mink, MD, Co-Founder and Chief Executive Officer of Beluga Health. "Collaborating with Dario allows us to extend that impact upstream, activating members earlier
More news about: DarioHealth Corp.
Jun 29, 2026, 06:53 ET Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist
excited about the successful completion of our Phase I clinical trial and double down on our efforts to bring the compound to patients", says Uli Brödl, MD, Chief Scientific Officer at Grünenthal. "With selective nociceptin receptor activation, Grünenthal hopes to introduce a new mechanism of action into
More news about: Grünenthal Group